Oral Cavity Cancer
📧 Sign up to get email alerts when something new happens for Oral Cavity Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor [Phase 1]
Phase 1 trial of an autologous dendritic cell vaccine transfected with a patient’s tumor DNA for oral cavity and oropharyngeal cancers was t…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer [Phase 1]
Phase 1 trial of photodynamic therapy with HPPH for recurrent dysplasia, carcinoma in situ, or stage I oral cavity cancer; the study sponsor…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]
This Phase 2 study evaluated valproic acid in combination with platinum-based chemoradiation for locally advanced head and neck squamous cel…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Smoking Status and Body Image in Oral Cancer Patients
A completed clinical trial update from MD Anderson Cancer Center examining smoking status and body image in patients with oral cavity cancer…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab [Phase 2]
This Phase II randomized trial assessed cetuximab with sorafenib versus cetuximab alone in metastatic head and neck squamous cell carcinomas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial update for cediranib maleate in patients with recurrent or metastatic head and neck squamous cell carcinoma has completed en…
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: A Study of High-Risk Oral Cavity Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial studying high-risk oral cavity cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer [EARLY_Phase 1]
An early-phase trial comparing intra-arterial versus intravenous cisplatin with radiation for oral cavity and oropharyngeal cancers was term…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity
The study provides a clinical trial update on quality-of-life assessment development for patients with oral cavity cancer. It focuses on cre…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat [NA]
This ClinicalTrials.gov entry reports termination of a study evaluating photodynamic therapy with porfimer sodium for recurrent mouth or thr…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating physiotherapy treatment for head and neck cancer patients, including those with oral cavity cancer and oro…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This document provides an update on a Phase 2 trial of sorafenib for patients with recurrent or metastatic head and neck cancer and indicate…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck [Phase 2]
This Phase 2 trial update examines bortezomib followed by doxorubicin at progression in patients with locally advanced, recurrent, or metast…
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer [Phase 3]
Phase 3 trial evaluating prevention of radiation-induced severe oral mucositis in cancers of the oral cavity, oropharynx, and hypopharynx ha…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat [Phase 2]
Phase 2 clinical trial S0011 evaluating gene therapy with surgery followed by chemotherapy and radiotherapy for newly diagnosed head and nec…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC [Phase 3]
Phase 3 trial assessing accelerated radiotherapy with concomitant chemoradiotherapy for head and neck squamous cell carcinoma has completed.